4 ms·
For orphaned drugs, companies have a monopoly status on it and clients litteraly can’t forgo buying, and will do whatever research is needed to find the product
by hrktb 8y ago
For orphaned drugs, companies have a monopoly status on it and clients litteraly can’t forgo buying, and will do whatever research is needed to find the product. There is no nudging or bribing the doctor or whatever is needed to take an edge.
Considering it’s long argued that one of the main cost of a drug is marketing [0], for any drug where it’s significantly more than 100 people we shoudn’t get these crazy prices.
[0] http://naturalsociety.com/research-development-new-drugs-not-paying-off-6321/ http://naturalsociety.com/research-development-new-drugs-not...
- ekianjo 8y agoYou are missing a major point. Lots of people who have rare disease are not even aware they have them, or not even diagnosed because their local doctor has never seen it before and mistook it for something else. So yes, you still need "marketing" to spread awareness for rare diseases, because they are, well, rare.
- techbio 8y agoYet the CDC is effective at spreading awareness of common diseases. Why do this via drug marketing?